RecruitingNCT07642882

Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients

A short description of this study’s research objective has not yet been verified.

Device studyAges 18–80FranceDepression

The study in practice

Understand this study

Listed age limits: 18 years to 80 years.

Listed locations: Boulogne-Billancourt, FranceSee all locations and recruitment
Activities: Device procedures described in the protocol · Sham comparator
Compensation: Payment and expense reimbursement have not been verified.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateEstimated: September 2026

Recruitment status: Recruiting
Enrollment listed in the registry: 36
Sponsor: Hospital Ambroise Paré Paris
Sponsor type: Hospital / academic medical center
Study type: Device
Intervention type: DEVICE
Study phase: Not clearly listed
Locations: France
Age range: From 18 Years to 80 Years
Official registry ID: NCT07642882
Official title: Analgesic Efficacy of Multisite rTMS in Depressed and Nondepressed Patients With Fibromyalgia and Prediction of the Response: a Double-Blind Randomized Sham-Controlled Study.

Study ID: NCT07642882. We help you review the study, but cannot decide medical eligibility.

Recruiting

Boulogne-Billancourt

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Hospital Ambroise Paré Paris, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.